![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/198 | (2006.01) |
A61K 31/198 | (2013.01) | ||
A61K 9/08 | (2006.01) | ||
A61K 9/08 | (2013.01) | ||
A61K 47/10 | (2017.01) | ||
A61K 47/10 | (2013.01) | ||
A61P 5/14 | (2006.01) | ||
A61P 5/14 | (2018.01) | ||
A61K 9/0095 | (2013.01) |
(11) | Patento numeris | 3930703 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 20705746.4 |
Europos patento paraiškos padavimo data | 2020-02-25 | |
(97) | Europos patento paraiškos paskelbimo data | 2022-01-05 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-12-27 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2020/054873 |
Data | 2020-02-25 |
(87) | Numeris | WO 2020/178074 |
Data | 2020-09-10 |
(30) | Numeris | Data | Šalis |
201900003013 | 2019-03-01 | IT |
(72) |
FOSSATI, Tiziano , CH
MAUTONE, Giuseppe , CH
SCARSI, Claudia , CH
|
(73) |
Altergon S.A. ,
Via Dogana Vecchia 2, 6900 Lugano,
CH
|
(54) | ADMINISTRATION REGIMEN OF SOLUTIONS OF T4 THYROID HORMONE WITH HIGH ORAL ABSORPTION |
ADMINISTRATION REGIMEN OF SOLUTIONS OF T4 THYROID HORMONE WITH HIGH ORAL ABSORPTION |